Skip to main content

Find Clinical Trials

Home
Conditions
Desmoplastic Small Round Cell Tumor

Clinical trial condition

Desmoplastic Small Round Cell Tumor

Explore clinical trials studying Desmoplastic Small Round Cell Tumor. Study availability and eligibility vary by location and protocol.

45 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Desmoplastic Small Round Cell Tumor trial results

Active, Not Recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT04483778

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations: Lucile Packard Children's Hospital Palo Alto, California, United States

Memorial Sloan Kettering Cancer Center New York, United States

Duke University Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

View Trial Details

Active, Not Recruiting

Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors

NCT01946529

Conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma of Bone or Soft Tissue, Localized Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, +12 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, Not Recruiting

EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT03618381

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +60 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

NCT01189643

Conditions: Desmoplastic Small Round Cell Tumor, Desmoplastic Small Round Cell Tumor (DSRCT), Neoplasms, +3 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details